Scholarly Index
Angela DeMichele
University of Pennsylvania; 27,667 total citations; 543 total publications; best world rank #24
University of Pennsylvania
27,667Total citations
543Total publications
88H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Advanced Breast Cancer Therapies | Lifetime | 61 | US 28 | 99.43 |
| HER2/EGFR in Cancer Research | Lifetime | 165 | US 81 | 99.22 |
| Cancer Treatment and Pharmacology | Lifetime | 307 | US 170 | 99.07 |
| Breast Cancer Treatment Studies | Lifetime | 334 | US 170 | 98.96 |
| Cancer-related Molecular Pathways | Lifetime | 457 | US 263 | 98.39 |
| Cancer survivorship and care | Lifetime | 801 | US 368 | 95.73 |
| Chemotherapy-induced cardiotoxicity and mitigation | Lifetime | 889 | US 361 | 87.71 |
| Cancer-related cognitive impairment studies | Lifetime | 845 | US 430 | 85.51 |
| Breast Cancer Treatment Studies | 2021-2025 | 59 | US 25 | 99.15 |
| Advanced Breast Cancer Therapies | 2021-2025 | 37 | US 15 | 99.28 |
| Cancer-related Molecular Pathways | 2021-2025 | 24 | US 13 | 98.09 |
| HER2/EGFR in Cancer Research | 2021-2025 | 99 | US 34 | 98.46 |
| Cancer Treatment and Pharmacology | 2021-2025 | 128 | US 41 | 97.47 |
| Cancer Genomics and Diagnostics | 2021-2025 | 849 | US 366 | 95.06 |
| Cancer Cells and Metastasis | 2021-2025 | 326 | US 94 | 91.24 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 817 | US 203 | 81.22 |
| Cancer Risks and Factors | 2021-2025 | 521 | US 189 | 82.21 |